Is it safe to take Ondansetron (ondansetron) while breastfeeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ondansetron Safety During Breastfeeding

Yes, ondansetron is safe to use while breastfeeding. 1

Evidence-Based Recommendation

The Association of Anaesthetists 2020 guideline explicitly lists ondansetron among anti-emetic medications that are compatible with breastfeeding, categorizing it alongside other safe peri-operative drugs. 1 While the guideline acknowledges that there are no human studies on transfer into breast milk (only animal data), ondansetron is included in their table of drugs safe for use in breastfeeding women without any special precautions or waiting periods. 1

Key Clinical Points

Transfer to Breast Milk

  • No human data exists on ondansetron transfer into breast milk, though animal studies provide some information. 1
  • The lack of human studies does not preclude its use, as the guideline explicitly endorses its safety based on pharmacokinetic principles and clinical experience. 1

Practical Application

  • No waiting period is required before resuming breastfeeding after ondansetron administration. 1
  • Ondansetron can be used for both acute management (such as in food protein-induced enterocolitis syndrome) and peri-operative nausea/vomiting in breastfeeding women. 1
  • The medication is listed alongside other commonly used anti-emetics (granisetron, cyclizine, prochlorperazine, dexamethasone, metoclopramide, domperidone) that are all considered compatible with breastfeeding. 1

Important Caveats

Cardiac Considerations

  • Special caution is warranted in patients with underlying heart disease due to potential QT interval prolongation, though this is a general precaution not specific to breastfeeding. 1
  • This cardiac risk applies to the mother's safety rather than infant exposure through breast milk. 1

Dosing Context

  • The guideline's endorsement applies to standard clinical doses used for nausea and vomiting management. 1
  • Both intravenous and oral formulations are considered acceptable. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.